Symphony Health Solutions First to Offer Weekly Views of Pharmaceutical Sales Activity

Company Launches PHAST 2.0 Institutional Weekly and PHAST 2.0 Integrated Weekly, the First Weekly Audits of Institutional Market Data


HORSHAM, Pa., May 2, 2014 (GLOBE NEWSWIRE) -- Symphony Health Solutions, a provider of high-value market research, analytics and technology solutions for life sciences manufacturers, payers and providers, today announced it has become the first data provider to offer weekly views of pharmaceutical sales and prescription activity. The company today launched PHAST 2.0 Institutional Weekly and PHAST 2.0 Integrated Weekly, the first weekly audits of U.S. institutional sales and overall market activity.

Previously available only on a monthly basis, the two new audits give customers more timely access to an abundance of institutional and prescription market data. Pharmaceutical manufacturers and financial analysts can use the data to closely monitor drug launches and the activity of competitive drugs in the marketplace. In addition, the integrated audit has been further enhanced with additional data on specialty drugs in a number of areas including oncology, rheumatoid arthritis and HIV.

PHAST 2.0 Integrated Weekly gives a combined view of retail pharmacy activity together with non-retail institutional sales to provide a comprehensive view of the market. PHAST 2.0 Institutional Weekly offers a view of pharmaceutical product sales to institutions, such as hospitals, clinics and long-term care facilities. These products complement PHAST 2.0 Prescription Weekly, one of the fastest and most comprehensive solutions for the analysis of prescription activity at U.S. retail, mail order, and specialty pharmacies.

"These new weekly audits allow us to provide the most comprehensive and timely coverage of both retail prescription activity and non-retail sales," said Don Otterbein, SVP, Product Management & Marketing, Symphony Health Solutions.  "Given the rate and pace of change in the healthcare and life sciences markets, it is increasingly important for our clients to have timely and actionable market intelligence to compete effectively."

PHAST 2.0 leverages the industry's largest sample of both retail and institutional sales data to give brand managers, market researchers and financial analysts the most comprehensive view of the market and can be accessed via a cutting-edge business intelligence tool. Using a new, easy-to-manage interface, customers now have access to dynamic visualization tools that allow them to analyze and present data in a variety of actionable formats.   

PHAST 2.0 Institutional Weekly and PHAST 2.0 Integrated Weekly are available this month.  For more information visit the Symphony Health Solutions website at www.symphonyhealth.com.

About Symphony Health Solutions

Symphony Health Solutions is a leading provider of high-value data, analytics, technology solutions and actionable insights for healthcare and life sciences manufacturers, payers and providers. The company helps clients improve commercial effectiveness, while adapting to the transformation of the healthcare ecosystem, by integrating a broad set of patient, prescriber, payer and clinical data together with primary and secondary health research, analytics and consulting. Symphony delivers a comprehensive perspective on the real dynamics that drive business in the healthcare and life sciences markets.  For more information, visit www.symphonyhealth.com.


            

Contact Data